Dr. Prasun Mishra

Founder and CEO Agility Pharmaceuticals, San Francisco, USA

Dr. Mishra (formerly with Genentech, Roche, NCI, NIH, DHHS, US Government) is a seasoned innovation executive leading research efforts focused on preventing and curing COVID-19, cancer, and other chronic diseases. His passion for drug development and precision medicine has led to identification of new drug targets, biomarkers, companion diagnostics, and several drugs/ combinations in the clinic.

Widely recognized as a technology and healthcare thought leader, Dr. Mishra has keynoted, chaired, curated, and organized numerous successful international conferences. His research work has been recognized globally by over 40 prestigious awards and honors. Due to his unique perspective & selfless service, he is highly respected & sought-after mentor to many.

• Drug discovery & development
• Robotization & automation
• BigData analytics & AI driven R&D
• Genetics, cancer genomics, bioinformatics
• Stem cells, tumor microenvironment
• Oncology, Immunology, inflamation, fibrosis & anti-aging
• Translational & clinical research